Summary by Futu AI
Steven P. Coen, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA), completed a series of transactions involving the company's Class A Common Stock. On May 31, 2024, Coen acquired a total of 29,745 shares through the exercise or conversion of derivative securities, at no reported transaction price. Subsequently, on June 3, 2024, Coen sold 13,440 shares in an open market transaction at a price of $0.549 per share, totaling a market value of $7,378.56. After these transactions, Coen's direct holdings in Ginkgo Bioworks amounted to 178,832 shares of Class A Common Stock.